P/E at 60.83 vs Industry's 60.64: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium or Parity?

The current P/E of Apollo Hospitals Enterprise Ltd. stands at 60.83, marginally above the hospital industry average of 60.64. This near-equal valuation suggests that the market is pricing the company in line with its sector peers, reflecting neither a significant premium nor a discount. Given the company’s large-cap status with a market capitalisation of ₹1,19,189.57 crores, this valuation level indicates investor confidence in its earnings stability and growth prospects relative to the broader hospital industry. However, the slight premium may also imply expectations of superior operational performance or market positioning. Previously rated Hold, what is Apollo Hospitals’ current rating? The four-parameter analysis factors in the valuation premium.

Performance Across Timeframes: Momentum Divergence

Examining the stock’s returns reveals a compelling divergence between short- and medium-term performance. Over the past year, Apollo Hospitals Enterprise Ltd. has delivered a robust 19.52% gain, significantly outperforming the Sensex’s 6.76% loss during the same period. This outperformance extends to longer horizons as well, with three-year and five-year returns of 78.42% and 163.29% respectively, dwarfing the Sensex’s 21.12% and 48.02% gains. Even the ten-year return of 515.88% versus the Sensex’s 185.58% underscores the company’s sustained growth trajectory.

Yet, the recent short-term data shows a more cautious tone. The stock declined by 0.84% over the last week, underperforming the Sensex’s 0.93% gain. Despite a positive one-month return of 7.60% and a three-month gain of 6.00%, these figures are modest compared to the longer-term strength. The year-to-date return of 17.70% remains healthy but is tempered by the recent weekly softness. This pattern suggests a potential pause or consolidation phase after a strong rally — is this a temporary correction or a sign of shifting market sentiment?

Moving Average Configuration: Technical Insights

The technical setup for Apollo Hospitals Enterprise Ltd. offers further clarity on its recent price action. The stock currently trades above its 20-day, 50-day, 100-day, and 200-day moving averages, signalling a generally bullish medium- to long-term trend. However, it remains below its 5-day moving average, indicating some short-term selling pressure or profit-taking. This configuration often points to a recent pullback within an ongoing uptrend, rather than a full reversal.

The proximity to its 52-week high is notable as well, with the stock just 4.17% shy of the peak price of ₹8,490.3. This closeness to the high suggests resilience and underlying strength, despite the minor short-term weakness. The 0.16% gain on the latest trading day, although slightly underperforming the hospital sector by 1.01%, reinforces the notion of a stock consolidating near its highs rather than breaking down. The 5% surge partially reverses a 6.45% monthly decline — is this a genuine recovery or a relief rally that will fade at the 50 DMA? — the moving average configuration provides the clearest answer.

Sector Performance Context

The hospital sector, to which Apollo Hospitals Enterprise Ltd. belongs, has experienced mixed results recently. While some companies in the sector have posted positive gains, others have remained flat or declined, reflecting a varied recovery landscape post-pandemic. The sector’s average P/E of 60.64 indicates a high valuation environment, consistent with the premium placed on healthcare services amid ongoing demand for quality medical infrastructure.

Within this context, Apollo Hospitals maintains a valuation in line with peers, suggesting that its earnings growth and market position are broadly recognised. The sector’s mixed performance also highlights the importance of company-specific factors in driving stock returns, rather than broad sector tailwinds alone.

Rating Reassessment and Historical Context

On 11 May 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from a previous Hold to a new assessment. This change reflects a reassessment of the company’s fundamentals, valuation, and technicals, with a current Mojo Score of 78.0. The rating update comes amid the company’s strong multi-year performance, including a 78.42% return over three years and an impressive 515.88% gain over ten years, underscoring its long-term growth credentials.

Despite the recent short-term volatility, the rating revision suggests confidence in the company’s ability to sustain its earnings momentum and market leadership. Should investors in Apollo Hospitals hold, buy more, or reconsider? The current rating provides the answer.

Conclusion: What the Data Collectively Shows

The data for Apollo Hospitals Enterprise Ltd. reveals a stock trading at a valuation closely aligned with its hospital industry peers, supported by strong long-term returns and a recent rating reassessment. The divergence between robust one-year and longer-term gains versus short-term softness suggests a stock in consolidation rather than decline. Its technical position above key moving averages but below the 5-day average indicates a short-term pause within a broader uptrend.

Sector performance remains mixed, reinforcing the importance of company-specific fundamentals in driving returns. The rating update from Hold to a new assessment reflects this nuanced picture, balancing valuation, performance, and technical factors. Is this the right moment to adjust exposure to Apollo Hospitals, or should investors maintain their current stance?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →